BSA Icon

4. BIOTECH SUMMIT AUSTRIA 2026

13 – 14 Oct 2026 | Innsbruck, Austria

ServiceUpdated on 13 October 2026

Advanced LNP & Nanomedicine Evaluation

Head of institute HEALTH at Joanneum Research Forschungsges. mbH

Graz, Austria

About

JOANNEUM RESEARCH HEALTH accelerates the development of innovative nanomedicines by providing specialized solutions for the preclinical evaluation, bioanalysis, and in-vivo tracking of Lipid Nanoparticles (LNPs). We help biotech partners optimize formulation performance and validate tissue-specific delivery.

Core Services & Applications

• In-Vivo Biodistribution & Tissue Targeting: Quantitative tracking of LNPs in specific target tissues (e.g., brain, skin, adipose tissue) utilizing our proprietary Open Flow Microperfusion (OFM) technology.

• Blood-Brain Barrier (BBB) Penetration: Utilizing cOFM to directly measure the efficiency of surface-engineered LNPs in crossing the intact blood-brain barrier into the interstitial fluid of the brain.

• High-End Lipid Analytics: GLP-compliant quantification of individual lipid components (e.g., ionizable lipids, helper lipids, cholesterol, and PEG-lipids) in biological matrices using advanced LC-MS/MS.

• Cargo-Agnostic PK/PD Profiling: Simultaneous monitoring of vehicle stability and active ingredient release directly at the site of action.

Organisation

Similar opportunities